RECRUITING

REACH-Es: Adapting a Digital Health Tool to Improve Diabetes Medication Adherence Among Latino Adults

Description

Latino individuals, the fastest growing ethnic minority population in the United States, have a higher prevalence of type 2 diabetes and diabetes-related complications, and are more likely to report inconsistent use of diabetes medications than non-Hispanic White individuals. The proposed project will test an interactive text message-based tool tailored to address barriers to taking diabetes medications that are relevant to Latino adults. If found feasible, acceptable, and usable, this intervention could serve as a scalable tool to improve diabetes management and reduce diabetes-related complications among Latino adults in the United States.

Study Overview

Study Details

Study overview

Latino individuals, the fastest growing ethnic minority population in the United States, have a higher prevalence of type 2 diabetes and diabetes-related complications, and are more likely to report inconsistent use of diabetes medications than non-Hispanic White individuals. The proposed project will test an interactive text message-based tool tailored to address barriers to taking diabetes medications that are relevant to Latino adults. If found feasible, acceptable, and usable, this intervention could serve as a scalable tool to improve diabetes management and reduce diabetes-related complications among Latino adults in the United States.

REACH-Es: Adapting a Digital Health Tool to Improve Diabetes Medication Adherence Among Latino Adults

REACH-Es: Adapting a Digital Health Tool to Improve Diabetes Medication Adherence Among Latino Adults

Condition
Type 2 Diabetes (Adult Onset)
Intervention / Treatment

-

Contacts and Locations

Boston

Massachusetts General Hospital Diabetes Research Center, Boston, Massachusetts, United States, 02114

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Type 2 diabetes mellitus
  • * Have current or prior (since 2018) HbA1c ≥8.0%
  • * Take at least one diabetes medication
  • * Receive care at MGH- affiliated primary care practices (≥2 visits in the past 3 years)
  • * ≥18 yrs
  • * Identify as Latino and/or Hispanic
  • * Speak and read in Spanish as preferred language
  • * Willing and able to provide informed consent
  • * Access to a mobile telephone with text messaging capability
  • * Suboptimal diabetes medication adherence, assessed using the first 2 items in the Adherence to Refill and Medication Scale (ARMS-d) questionnaire combined: "How frequently do you forget or decide to not take your diabetes medications?" Participants who answer sometimes, almost always, and/or always will be considered eligible for the study.
  • * Auditory limitations and/or inability to communicate orally
  • * Inability to receive, read, or send a text message (assessed by a trained research assistant)

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Massachusetts General Hospital,

Jacqueline Seiglie, PRINCIPAL_INVESTIGATOR, Massachusetts General Hospital

Study Record Dates

2027-02-28